NCT02640976View on ClinicalTrials.gov

Poor Ovarian Stimulation Response in In Vitro Fertilization (IVF) Program

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

216

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

June 30, 2015

Study Completion Date

August 31, 2015

Conditions
Infertility
Interventions
DRUG

Human menopausal gonadotrophin (HMG)

\[Merional® 75 IU ampoules, IBSA institut\]

DRUG

GnRH antagonist Cetrorelix

\[Cetrotide® 0.25 mg syringes, Merck Serono\]

DRUG

Human chorionic gonadotrophin (hCG)

\[Choriomon® 5000 IU ampoules, IBSA institut\]

All Listed Sponsors
lead

Cairo University

OTHER

NCT02640976 - Poor Ovarian Stimulation Response in In Vitro Fertilization (IVF) Program | Biotech Hunter | Biotech Hunter